Assenagon Asset Management S.A. Roivant Sciences Ltd. Transaction History
Assenagon Asset Management S.A.
- $54.8 Billion
- Q1 2025
A detailed history of Assenagon Asset Management S.A. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 56,537 shares of ROIV stock, worth $635,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,537Holding current value
$635,475% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$740 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$695 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$517 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$458 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$404 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.92B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...